These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38214606)

  • 1. RBCK1 overexpression is associated with immune cell infiltration and poor prognosis in hepatocellular carcinoma.
    Yu J; Liu T; Liu M; Jin H; Wei Z
    Aging (Albany NY); 2024 Jan; 16(1):538-549. PubMed ID: 38214606
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive Multi-Omics Identification of Interferon-γ Response Characteristics Reveals That RBCK1 Regulates the Immunosuppressive Microenvironment of Renal Cell Carcinoma.
    Xu W; Tao J; Zhu W; Liu W; Anwaier A; Tian X; Su J; Shi G; Huang H; Wei G; Li C; Qu Y; Zhang H; Ye D
    Front Immunol; 2021; 12():734646. PubMed ID: 34795663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CDC20 as an immune infiltration-correlated prognostic biomarker in hepatocellular carcinoma.
    Xiong C; Wang Z; Wang G; Zhang C; Jin S; Jiang G; Bai D
    Invest New Drugs; 2021 Oct; 39(5):1439-1453. PubMed ID: 33942202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypoxia-induced degradation of PICK1 by RBCK1 promotes the proliferation of nasopharyngeal carcinoma cells.
    Zhang Y; Lu Y; Xu Y; Le Z; Liu Y; Tu W; Liu Y
    Life Sci; 2023 May; 321():121594. PubMed ID: 36934971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of PTEN and ovarian cancer progression by an E3 ubiquitin ligase RBCK1.
    Wang G; Zhuang Z; Shen S; Yang F; Jiang Z; Liu Z; Wang T; Hua L
    Hum Cell; 2022 May; 35(3):896-908. PubMed ID: 35174471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3.
    Zhang M; Tian Y; Wang RP; Gao D; Zhang Y; Diao FC; Chen DY; Zhai ZH; Shu HB
    Cell Res; 2008 Nov; 18(11):1096-104. PubMed ID: 18711448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor-α, RBCK1, and protein kinase C β 1 cooperate to regulate estrogen receptor-α gene expression.
    Gustafsson Sheppard N; Heldring N; Dahlman-Wright K
    J Mol Endocrinol; 2012 Dec; 49(3):277-87. PubMed ID: 23042805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The E3 ubiquitin ligase RBCK1 promotes the invasion and metastasis of hepatocellular carcinoma by destroying the PPARγ/PGC1α complex.
    Xu Z; Shao J; Zheng C; Cai J; Li B; Peng X; Chen L; Liu T
    Am J Cancer Res; 2022; 12(3):1372-1392. PubMed ID: 35411229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative proteomics reveals the role of E3 ubiquitin ligase SYVN1 in hepatocellular carcinoma metastasis.
    Ji F; Zhou M; Sun Z; Jiang Z; Zhu H; Xie Z; Ouyang X; Zhang L; Li L
    Cancer Commun (Lond); 2021 Oct; 41(10):1007-1023. PubMed ID: 34196494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBCK1 promotes hepatocellular carcinoma metastasis and growth by stabilizing RNF31.
    Chen X; Ye Q; Zhao W; Chi X; Xie C; Wang X
    Cell Death Discov; 2022 Jul; 8(1):334. PubMed ID: 35869046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of ubiquitin ligase activity of RBCK1 and its inhibition by splice variant RBCK2 and protein kinase Cbeta.
    Tatematsu K; Yoshimoto N; Okajima T; Tanizawa K; Kuroda S
    J Biol Chem; 2008 Apr; 283(17):11575-85. PubMed ID: 18303026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RBCK1, an E3 ubiquitin ligase, interacts with and ubiquinates the human pregnane X receptor.
    Rana R; Coulter S; Kinyamu H; Goldstein JA
    Drug Metab Dispos; 2013 Feb; 41(2):398-405. PubMed ID: 23160820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a circRNA-regulated E3 ubiquitin ligase signature and nomogram to predict immunotherapeutic efficacy and prognosis in hepatocellular carcinoma.
    Wu G; Zhang J; Peng R; Cao J; Tu D; Zhou J; Su B; Jin S; Jiang G; Zhang C; Bai D
    Eur J Med Res; 2024 Jun; 29(1):318. PubMed ID: 38858746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein.
    Zang HL; Ren SN; Cao H; Tian XF
    IUBMB Life; 2017 Oct; 69(10):795-801. PubMed ID: 28861931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 ubiquitin ligase RBCK1: Implications in the tumor immune microenvironment and antiangiogenic therapy of glioma.
    Guo J; Sun D; Zhang J; Guo J; Wu Z; Chen Y; Xu Y; Zhou D; Cui Y; Mo Q; Li Y; Zhao T; You Q
    Comput Struct Biotechnol J; 2023; 21():5212-5227. PubMed ID: 37928949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fbxw7 is an independent prognostic marker and induces apoptosis and growth arrest by regulating YAP abundance in hepatocellular carcinoma.
    Tu K; Yang W; Li C; Zheng X; Lu Z; Guo C; Yao Y; Liu Q
    Mol Cancer; 2014 May; 13():110. PubMed ID: 24884509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RBCK1 promotes p53 degradation via ubiquitination in renal cell carcinoma.
    Yu S; Dai J; Ma M; Xu T; Kong Y; Cui C; Chi Z; Si L; Tang H; Yang L; Sheng X; Guo J
    Cell Death Dis; 2019 Mar; 10(4):254. PubMed ID: 30874541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis.
    Wang Y; Peng M; Zhong Y; Xiong W; Zhu L; Jin X
    Oncogene; 2023 Mar; 42(13):952-966. PubMed ID: 36732658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E3 ubiquitin ligase RBCK1 confers ferroptosis resistance in pancreatic cancer by facilitating MFN2 degradation.
    Su D; Ding C; Wang R; Qiu J; Liu Y; Tao J; Luo W; Weng G; Yang G; Zhang T
    Free Radic Biol Med; 2024 Aug; 221():136-154. PubMed ID: 38763208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear expression of the ubiquitin ligase seven in absentia homolog (SIAH)-1 induces proliferation and migration of liver cancer cells.
    Brauckhoff A; Malz M; Tschaharganeh D; Malek N; Weber A; Riener MO; Soll C; Samarin J; Bissinger M; Schmidt J; Longerich T; Ehemann V; Schirmacher P; Breuhahn K
    J Hepatol; 2011 Nov; 55(5):1049-57. PubMed ID: 21356256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.